Shinobu Suzuki
InvestorScientific Advisor, RDiscovery at Remiges Ventures, Inc.
About
Shinobu Suzuki earned a Ph.D. in Pharmaceutical Sciences from Osaka University and conducted basic research in molecular biology and immunology at UCLA, University of Toronto, and RIKEN Yokohama Institute. She led open innovation and drug discovery activities at global pharmaceutical companies including Bayer, AbbVie, and Boehringer Ingelheim, and since 2019 has worked at Kyoto University fostering academia-industry partnerships.
Colleagues at Remiges Ventures, Inc.
Atsushi Uno
Senior Researcher at Remiges Ventures, Inc.
Hans Keirstead
Chairman at Remiges Ventures, Inc.
Hiroshi Tamada
Chief Medical Officer at Remiges Ventures, Inc.
Hiroshi Tamada
Chief Medical Officer at RDiscovery
Kanako Amano
Researcher at Remiges Ventures, Inc.
Kazuhiko Nonomura
Partner at Remiges Ventures, Inc.
Kyoko Matsumoto
Senior Associate at Remiges Ventures, Inc.
Linda Li
Venture Partner at Remiges Ventures, Inc.
Frequently asked questions
- Who is Shinobu Suzuki?
- Shinobu Suzuki earned a Ph.D. in Pharmaceutical Sciences from Osaka University and conducted basic research in molecular biology and immunology at UCLA, University of Toronto, and RIKEN Yokohama Institute. She led open innovation and drug discovery activities at global pharmaceutical companies including Bayer, AbbVie, and Boehringer Ingelheim, and since 2019 has worked at Kyoto University fostering academia-industry partnerships.
- Where does Shinobu Suzuki work?
- Shinobu Suzuki is Scientific Advisor, RDiscovery at Remiges Ventures, Inc..